Multinational pharmaceutical companies: principles and practices
Gespeichert in:
| Vorheriger Titel: | Spilker, Bert Multinational drug companies |
|---|---|
| 1. Verfasser: | |
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Press
1994
|
| Ausgabe: | 2. ed. |
| Schlagworte: | |
| Beschreibung: | 1. ed. u.d.T.: Spilker, Bert: Multinational drug companies |
| Beschreibung: | XL, 803 S. graph. Darst. |
| ISBN: | 0781701007 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV009552266 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 940425s1994 d||| |||| 00||| engod | ||
| 020 | |a 0781701007 |9 0-7817-0100-7 | ||
| 035 | |a (OCoLC)28587230 | ||
| 035 | |a (DE-599)BVBBV009552266 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 | ||
| 050 | 0 | |a HD9665.5 | |
| 082 | 0 | |a 338.8/8716151 |2 20 | |
| 100 | 1 | |a Spilker, Bert |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Multinational pharmaceutical companies |b principles and practices |c Bert Spilker |
| 250 | |a 2. ed. | ||
| 264 | 1 | |a New York |b Raven Press |c 1994 | |
| 300 | |a XL, 803 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a 1. ed. u.d.T.: Spilker, Bert: Multinational drug companies | ||
| 650 | 4 | |a Entreprises multinationales | |
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 4 | |a Industrie pharmaceutique | |
| 650 | 4 | |a Industrie pharmaceutique - Innovations | |
| 650 | 7 | |a Internationale ondernemingen |2 gtt | |
| 650 | 4 | |a Médicaments - Recherche - Gestion | |
| 650 | 7 | |a Technische vernieuwing |2 gtt | |
| 650 | 4 | |a Multinationales Unternehmen | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Drug Industry | |
| 650 | 4 | |a Drugs |x Research |x Management | |
| 650 | 4 | |a International business enterprises | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Pharmaceutical industry |x Technological innovations | |
| 650 | 4 | |a Research | |
| 650 | 0 | 7 | |a Multinationales Unternehmen |0 (DE-588)4075092-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Multinationales Unternehmen |0 (DE-588)4075092-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 780 | 0 | 0 | |i 1. Aufl. u.d.T. |a Spilker, Bert |t Multinational drug companies |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006310929 | ||
Datensatz im Suchindex
| _version_ | 1804123892765163520 |
|---|---|
| any_adam_object | |
| author | Spilker, Bert |
| author_facet | Spilker, Bert |
| author_role | aut |
| author_sort | Spilker, Bert |
| author_variant | b s bs |
| building | Verbundindex |
| bvnumber | BV009552266 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9665 |
| callnumber-raw | HD9665.5 |
| callnumber-search | HD9665.5 |
| callnumber-sort | HD 49665.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| ctrlnum | (OCoLC)28587230 (DE-599)BVBBV009552266 |
| dewey-full | 338.8/8716151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.8/8716151 |
| dewey-search | 338.8/8716151 |
| dewey-sort | 3338.8 78716151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | 2. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01953nam a2200553 c 4500</leader><controlfield tag="001">BV009552266</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940425s1994 d||| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0781701007</subfield><subfield code="9">0-7817-0100-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28587230</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009552266</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.8/8716151</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Spilker, Bert</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multinational pharmaceutical companies</subfield><subfield code="b">principles and practices</subfield><subfield code="c">Bert Spilker</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Press</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XL, 803 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">1. ed. u.d.T.: Spilker, Bert: Multinational drug companies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entreprises multinationales</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - Innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Internationale ondernemingen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche - Gestion</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Technische vernieuwing</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multinationales Unternehmen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">International business enterprises</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Technological innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Multinationales Unternehmen</subfield><subfield code="0">(DE-588)4075092-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Multinationales Unternehmen</subfield><subfield code="0">(DE-588)4075092-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="780" ind1="0" ind2="0"><subfield code="i">1. Aufl. u.d.T.</subfield><subfield code="a">Spilker, Bert</subfield><subfield code="t">Multinational drug companies</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006310929</subfield></datafield></record></collection> |
| id | DE-604.BV009552266 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:37:00Z |
| institution | BVB |
| isbn | 0781701007 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006310929 |
| oclc_num | 28587230 |
| open_access_boolean | |
| owner | DE-12 DE-188 |
| owner_facet | DE-12 DE-188 |
| physical | XL, 803 S. graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Raven Press |
| record_format | marc |
| spelling | Spilker, Bert Verfasser aut Multinational pharmaceutical companies principles and practices Bert Spilker 2. ed. New York Raven Press 1994 XL, 803 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier 1. ed. u.d.T.: Spilker, Bert: Multinational drug companies Entreprises multinationales Farmaceutische industrie gtt Industrie pharmaceutique Industrie pharmaceutique - Innovations Internationale ondernemingen gtt Médicaments - Recherche - Gestion Technische vernieuwing gtt Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Multinationales Unternehmen (DE-588)4075092-9 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 s Multinationales Unternehmen (DE-588)4075092-9 s DE-604 1. Aufl. u.d.T. Spilker, Bert Multinational drug companies |
| spellingShingle | Spilker, Bert Multinational pharmaceutical companies principles and practices Entreprises multinationales Farmaceutische industrie gtt Industrie pharmaceutique Industrie pharmaceutique - Innovations Internationale ondernemingen gtt Médicaments - Recherche - Gestion Technische vernieuwing gtt Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Multinationales Unternehmen (DE-588)4075092-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| subject_GND | (DE-588)4075092-9 (DE-588)4045696-1 |
| title | Multinational pharmaceutical companies principles and practices |
| title_auth | Multinational pharmaceutical companies principles and practices |
| title_exact_search | Multinational pharmaceutical companies principles and practices |
| title_full | Multinational pharmaceutical companies principles and practices Bert Spilker |
| title_fullStr | Multinational pharmaceutical companies principles and practices Bert Spilker |
| title_full_unstemmed | Multinational pharmaceutical companies principles and practices Bert Spilker |
| title_old | Spilker, Bert Multinational drug companies |
| title_short | Multinational pharmaceutical companies |
| title_sort | multinational pharmaceutical companies principles and practices |
| title_sub | principles and practices |
| topic | Entreprises multinationales Farmaceutische industrie gtt Industrie pharmaceutique Industrie pharmaceutique - Innovations Internationale ondernemingen gtt Médicaments - Recherche - Gestion Technische vernieuwing gtt Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Multinationales Unternehmen (DE-588)4075092-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| topic_facet | Entreprises multinationales Farmaceutische industrie Industrie pharmaceutique Industrie pharmaceutique - Innovations Internationale ondernemingen Médicaments - Recherche - Gestion Technische vernieuwing Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Pharmazeutische Industrie |
| work_keys_str_mv | AT spilkerbert multinationalpharmaceuticalcompaniesprinciplesandpractices |